113 related articles for article (PubMed ID: 28522465)
1. CD34
Chen Y; Chang H
Blood; 2017 May; 129(20):2818. PubMed ID: 28522465
[No Abstract] [Full Text] [Related]
2. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
[TBL] [Abstract][Full Text] [Related]
3. Presence of CD34
Duarte FB; DE Jesus Dos Santos TE; Barbosa MC; Moura ATG; DE Vasconcelos JPL; Rocha-Filho FD; Coutinho DF; Zalcberg I; Vasconcelos PRL; Garcia YDO; Lemes RPG
In Vivo; 2019; 33(1):277-280. PubMed ID: 30587636
[TBL] [Abstract][Full Text] [Related]
4. CD34/QBEND10 immunostaining in the bone marrow trephine biopsy: a study of CD34-positive mononuclear cells and megakaryocytes.
Torlakovic G; Langholm R; Torlakovic E
Arch Pathol Lab Med; 2002 Jul; 126(7):823-8. PubMed ID: 12088452
[TBL] [Abstract][Full Text] [Related]
5. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
[TBL] [Abstract][Full Text] [Related]
6. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
7. Megakaryocytic ploidy in myelodysplastic syndromes.
Kobayashi Y; Ozawa M; Maruo N; Kondo M
Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes.
Li X; Pu Q
Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828
[TBL] [Abstract][Full Text] [Related]
9. Concurrent
Tremblay-LeMay R; Chang H
Blood; 2018 Jul; 132(1):112. PubMed ID: 29976782
[No Abstract] [Full Text] [Related]
10. Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.
Godon C; Talmant P; Garand R; Accart F; Bataille R; Avet-Loiseau H
Genes Chromosomes Cancer; 2000 Dec; 29(4):350-2. PubMed ID: 11066080
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD34 by megakaryocytes in myelodysplastic syndromes.
Pellegrini W; Facchetti F; Marocolo D; Pelizzari AM; Capucci A; Rossi G
Haematologica; 2000 Oct; 85(10):1117-8. PubMed ID: 11025619
[No Abstract] [Full Text] [Related]
12. Defective megakaryocytic development in myelodysplastic syndromes.
Hofmann WK; Kalina U; Koschmieder S; Seipelt G; Hoelzer D; Ottmann OG
Leuk Lymphoma; 2000 Jun; 38(1-2):13-9. PubMed ID: 10811444
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
14. Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients.
Kobayashi Y; Uoshima N; Kimura S; Tanaka K; Wada K; Ozawa M; Maruo N; Kondo M
Int J Hematol; 1995 Apr; 61(3):117-22. PubMed ID: 7599323
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytic emperipolesis: a histological finding in myelodysplastic syndrome.
Sable MN; Sehgal K; Gadage VS; Subramanian PG; Gujral S
Indian J Pathol Microbiol; 2009; 52(4):599-600. PubMed ID: 19805998
[No Abstract] [Full Text] [Related]
16. [Study about proliferation and apoptosis of megakaryocytes in patients with myelodysplastic syndromes].
Li X; Pu Q; Liu YZ; Shi J; Tao Y; Chang CK; Jiang QY; Huang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):40-3. PubMed ID: 12513835
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.
Houwerzijl EJ; Blom NR; van der Want JJ; Vellenga E; de Wolf JT
Leukemia; 2006 Nov; 20(11):1937-42. PubMed ID: 16990774
[TBL] [Abstract][Full Text] [Related]
18. "Ring-form" megakaryocytic dysplasia in STAG2-mutated myelodysplastic neoplasm.
Deb PQ; Xiao W
Blood; 2024 May; 143(21):2218. PubMed ID: 38780921
[No Abstract] [Full Text] [Related]
19. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
Mori H; Niikura H; Terada H; Fujita K
Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
[TBL] [Abstract][Full Text] [Related]
20. A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
Liu B; Ohishi K; Yamamura K; Suzuki K; Monma F; Ino K; Nishii K; Masuya M; Sekine T; Heike Y; Takaue Y; Katayama N
Exp Hematol; 2010 Aug; 38(8):685-95. PubMed ID: 20381581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
